ArticleSmall science2023
Nano-Metamaterial: A State-of-the-Art Material for Magnetic Resonance Imaging.
Article in Small science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analysis of an Ultra-Wideband, Perfectly Absorptive Fractal Absorber with a Central Square Nanopillar in a Cylindrical Structure with a Square Hollow.Materials (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metamaterials are artificially designed materials with multilevel-ordered microarchitectures, which exhibit extraordinary properties not occurring in nature, and their applications have been widely exploited in various research fields. However, the progress of metamaterials for biomedical applications is relatively slow, largely due to the limitations in the size tailoring. When reducing the maximum size of metamaterials to nanometer scale, their multilevel-ordered microarchitectures are expected to obtain superior functions beyond conventional nanomaterials with single-level microarchitectures, which will be a prospective candidate for the next-generation diagnostic and/or therapeutic agents. Here, a forward-looking discussion on the superiority of nano-metamaterials for magnetic resonance imaging (MRI) according to the imaging principles, which is attributed to the unique periodic arrangement of internal multilevel structural units in nano-metamaterials, is presented. Moreover, recent advances in the development of nano-metamaterials for high-performance MRI are introduced. Finally, the challenges and future perspectives of nano-metamaterials as promising MRI contrast agents for biomedical applications are briefly commented.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.